A Phase II Study of AZD2171 in Metastatic Androgen Independent Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 09 Oct 2018
At a glance
- Drugs Cediranib (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 20 Aug 2018 Status changed from active, no longer recruiting to completed.
- 09 Jan 2012 Planned end date changed from 1 Dec 2011 to 1 Dec 2013 as reported by ClinicalTrials.gov.